Literature DB >> 17510390

Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage.

Susan W P Wijnhoven1, Ewoud N Speksnijder, Xiaoling Liu, Edwin Zwart, Conny Th M vanOostrom, Rudolf B Beems, Esther M Hoogervorst, Mirjam M Schaap, Laura D Attardi, Tyler Jacks, Harry van Steeg, Jos Jonkers, Annemieke de Vries.   

Abstract

p53 alterations in human tumors often involve missense mutations that may confer dominant-negative or gain-of-function properties. Dominant-negative effects result in inactivation of wild-type p53 protein in heterozygous mutant cells and as such in a p53 null phenotype. Gain-of-function effects can directly promote tumor development or metastasis through antiapoptotic mechanisms or transcriptional activation of (onco)genes. Here, we show, using conditional mouse technology, that epithelium-specific heterozygous expression of mutant p53 (i.e., the p53.R270H mutation that is equivalent to the human hotspot R273H) results in an increased incidence of spontaneous and UVB-induced skin tumors. Expression of p53.R270H exerted dominant-negative effects on latency, multiplicity, and progression status of UVB-induced but not spontaneous tumors. Surprisingly, gain-of-function properties of p53.R270H were not detected in skin epithelium. Apparently, dominant-negative and gain-of-function effects of mutant p53 are highly tissue specific and become most manifest upon stabilization of p53 after DNA damage.

Entities:  

Mesh:

Year:  2007        PMID: 17510390     DOI: 10.1158/0008-5472.CAN-06-4681

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.

Authors:  Paola Monti; Chiara Perfumo; Alessandra Bisio; Yari Ciribilli; Paola Menichini; Debora Russo; David M Umbach; Michael A Resnick; Alberto Inga; Gilberto Fronza
Journal:  Mol Cancer Res       Date:  2011-02-22       Impact factor: 5.852

2.  Defining relative mutational difficulty to understand cancer formation.

Authors:  Lin Shan; Jiao Yu; Zhengjin He; Shishuang Chen; Mingxian Liu; Hongyu Ding; Liang Xu; Jie Zhao; Ailing Yang; Hai Jiang
Journal:  Cell Discov       Date:  2020-07-21       Impact factor: 10.849

3.  Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma.

Authors:  Kathleen M Schieffer; Elizabeth Varga; Katherine E Miller; Vibhuti Agarwal; Daniel C Koboldt; Patrick Brennan; Benjamin Kelly; Ashita Dave-Wala; Christopher R Pierson; Jonathan L Finlay; Mohamed S AbdelBaki; Peter White; Vincent Magrini; Richard K Wilson; Elaine R Mardis; Catherine E Cottrell
Journal:  Eur J Med Genet       Date:  2019-06-10       Impact factor: 2.708

4.  High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma.

Authors:  Jane Carr-Wilkinson; Kieran O'Toole; Katrina M Wood; Christine C Challen; Angela G Baker; Julian R Board; Laura Evans; Michael Cole; Nai-Kong V Cheung; Joachim Boos; Gabriele Köhler; Ivo Leuschner; Andrew D J Pearson; John Lunec; Deborah A Tweddle
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

5.  Mouse models for the p53 R72P polymorphism mimic human phenotypes.

Authors:  Feng Zhu; Martijn E T Dollé; Thomas R Berton; Raoul V Kuiper; Carrie Capps; Alexsandra Espejo; Mark J McArthur; Mark T Bedford; Harry van Steeg; Annemieke de Vries; David G Johnson
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

6.  Dominant negative mutations affect oligomerization of human pyruvate kinase M2 isozyme and promote cellular growth and polyploidy.

Authors:  Vibhor Gupta; Ponnusamy Kalaiarasan; Mohammad Faheem; Nishant Singh; Mohammad Askandar Iqbal; Rameshwar N K Bamezai
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

Review 7.  Chronic low dose UV exposure and p53 mutation: tilting the odds in early epidermal preneoplasia?

Authors:  Amit Roshan; Philip H Jones
Journal:  Int J Radiat Biol       Date:  2012-08-23       Impact factor: 2.694

8.  Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model.

Authors:  Jessica A Bertout; Shetal A Patel; Benjamin H Fryer; Amy C Durham; Kelly L Covello; Kenneth P Olive; Michael H Goldschmidt; M Celeste Simon
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

Review 9.  The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Authors:  Dawid Walerych; Marco Napoli; Licio Collavin; Giannino Del Sal
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

10.  Gene expression profiling of mouse p53-deficient epidermal carcinoma defines molecular determinants of human cancer malignancy.

Authors:  Ramón García-Escudero; Ana B Martínez-Cruz; Mirentxu Santos; Corina Lorz; Carmen Segrelles; Guillermo Garaulet; Cristina Saiz-Ladera; Clotilde Costa; Agueda Buitrago-Pérez; Marta Dueñas; Jesús M Paramio
Journal:  Mol Cancer       Date:  2010-07-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.